Ligence Heart vs Tempus ECG-Low EF
AI Verdict
Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department or echocardiography lab requires comprehensive, automated analysis and reporting of 2D transthoracic echocardiograms. This platform is ideal for enhancing diagnostic efficiency and accuracy by automating measurements, view classification, heart phase prediction, and disease recognition, streamlining the entire echo workflow from image transfer to report generation.
View Ligence Heart →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need a rapid, AI-powered screening tool to identify patients aged 40 or older at risk of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECG recordings. This solution is particularly well-suited for primary care, emergency medicine, or internal medicine settings to aid in early detection and guide further diagnostic evaluation for potential heart failure.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Ligence Heart | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Contact-for-pricing | Unknown |
| Deployment | Cloud-based; on-premise; hybrid | Integrates with current ECG platforms and electronic health records (EHRs). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartLigence Heart (Tool A) is a web-based platform designed for intuitive use, automating complex echocardiography analysis and report generation, which significantly streamlines workflow and saves time for cardiologists and sonographers [6, 11, 13, 15]. In contrast, Tempus ECG-Low EF (Tool B) lacks a dedicated user interface, integrating into existing workflows via standard communication protocols and providing only a binary output, offering less direct user interaction and comprehensive workflow automation [7].
Clinical Value
Ligence HeartLigence Heart (Tool A) offers a broader and more comprehensive diagnostic solution for echocardiography, automating detailed measurements, view classification, and disease recognition for multiple cardiac conditions with high accuracy, even outperforming human measurements in some studies [1, 2, 3, 15]. While Tempus ECG-Low EF (Tool B) provides crucial early detection of low LVEF from ECGs, its clinical utility is more focused as a screening aid rather than a comprehensive diagnostic tool [5, 8, 9].
Pricing & Value
TieBoth Ligence Heart (Tool A) and Tempus ECG-Low EF (Tool B) require direct contact with the vendor for pricing information, making it impossible to conduct a head-to-head comparison of their cost or value proposition [JSON]. Neither tool provides transparent, publicly available pricing details or specific cost-effectiveness data to determine a winner in this dimension [14].
Enterprise Readiness
Ligence HeartBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong regulatory and security readiness. However, Ligence Heart (Tool A) explicitly offers more flexible deployment options (cloud, on-premise, hybrid) and detailed integration capabilities with PACS, EHR, and RIS, including personalized solutions and APIs for unique system requirements [JSON, 6]. Tempus ECG-Low EF (Tool B) mentions integration into healthcare facility workflows via standard protocols but is less specific about deployment flexibility or custom integration options [JSON, 7].
Innovation
Ligence HeartLigence Heart (Tool A) demonstrates a higher degree of innovation by fully automating the complex and time-consuming process of 2D transthoracic echocardiography analysis, including detailed measurements, view classification, and comprehensive report generation for multiple diseases [JSON, 4, 6, 13]. Tempus ECG-Low EF (Tool B) is innovative in leveraging AI for early detection of low LVEF from standard ECGs, but its scope is more targeted to a specific screening function [JSON, 5, 8].
Support & Docs
Ligence HeartLigence Heart (Tool A) explicitly mentions providing technical support via email, software installation manuals, user manuals, and training videos for operators [2, 10, 12]. In contrast, the available information for Tempus ECG-Low EF (Tool B) does not detail specific user support channels, documentation portals, or training materials, making Ligence Heart appear more transparent in its support offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Ligence Heart | Tempus ECG-Low EF |
|---|---|---|
| Name | Ligence Heart | Tempus ECG-Low EF |
| Company | Ligence | Tempus |
| Description | Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Tagline | Echocardiography that makes sense. | Redefining the future of precision medicine. |
| Categories | Cardiology AI | Cardiology AI |
| Specialties | Cardiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Ligence Heart and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring Ligence Heart or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.